Evidence map›Paper›PMID 24863081›Full record

ArticleAnnals of internal medicine2014

What are cancer centers advertising to the public?: a content analysis.

Laura B Vater, Julie M Donohue, Robert Arnold, Douglas B White, Edward Chu, Yael Schenker

Abstract read
In one paragraph

Article in Annals of internal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Advertising Ban in Healthcare: A Qualitative Study from the Perspective of Private Hospital Managers in Türkiye.Health care analysis : HCA : journal of health philosophy and policy · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. "More than conquerors": a qualitative analysis of war metaphors for patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  12. Article
  13. Article
  14. Marketing the Research Missions of Academic Medical Centers: Why Messages Blurring Lines Between Clinical Care and Research Are Bad for both Business and Ethics.Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees · 2019
    Article
  15. Article
  16. When Religion and Medicine Clash: Non-beneficial Treatments and Hope for a Miracle.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2019
    Article
  17. Article
  18. Article
  19. Palliative care content on cancer center websites.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Laura B Vater
Julie M Donohue
Robert Arnold
Douglas B White
Edward Chu
Yael Schenker
University of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstitutionKL2TR000146 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$8.7M
NCATS NIH HHS KL2 TR000146NCATS NIH HHS KL2TR000146
6 · The paper itself

Abstract

backgroundAlthough critics have expressed concerns about cancer center advertising, analyses of the content of these advertisements are lacking.

objectiveTo characterize the informational and emotional content of direct-to-consumer cancer center advertisements.

designContent analysis.

settingTop U.S. consumer magazines (n = 269) and television networks (n = 44) in 2012. MEASUREMENTS: Types of clinical services promoted; information provided about clinical services, including risks, benefits, costs, and insurance availability; use of emotional advertising appeals; and use of patient testimonials were assessed. Two investigators independently coded advertisements using ATLAS.ti, and κ values ranged from 0.77 to 1.00.

resultsA total of 102 cancer centers placed 409 unique clinical advertisements in top media markets in 2012. Advertisements promoted treatments (88%) more often than screening (18%) or supportive services (13%). Benefits of advertised therapies were described more often than risks (27% vs. 2%) but were rarely quantified (2%). Few advertisements mentioned coverage or costs (5%), and none mentioned specific insurance plans. Emotional appeals were frequent (85%), evoking hope for survival (61%), describing cancer treatment as a fight or battle (41%), and inducing fear (30%). Nearly one half of advertisements included patient testimonials, which were usually focused on survival, rarely included disclaimers (15%), and never described the results that a typical patient may expect. LIMITATION: Internet advertisements were not included.

conclusionClinical advertisements by cancer centers frequently promote cancer therapy with emotional appeals that evoke hope and fear while rarely providing information about risks, benefits, costs, or insurance availability. Further work is needed to understand how these advertisements influence patient understanding and expectations of benefit from cancer treatments. PRIMARY FUNDING SOURCE: National Institutes of Health.

Indexed as

AdvertisingCancer Care FacilitiesMarketing of Health ServicesHumansNeoplasmsUnited States

Identifiers

PMID24863081
PMCPMC4356527
OpenAlexW2017720942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.